Announcements Trials

Browse Landscape

Phase

Status

Recruiting 5 Withdrawn 1 Unknown 1 Suspended 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1275 Carcinoma, Non-Small-Cell Lung 783 Neoplasms 767 Colorectal Neoplasms 755 Carcinoma, Hepatocellular 579 Stomach Neoplasms 578 Prostatic Neoplasms 501 Lung Neoplasms 461 Pancreatic Neoplasms 416 Rectal Neoplasms 331 Recurrence 312 Neoplasm Metastasis 305 Leukemia, Myeloid, Acute 289 Multiple Myeloma 281 Colonic Neoplasms 280 Lymphoma 273 Uterine Cervical Neoplasms 269 Esophageal Neoplasms 267 Ovarian Neoplasms 261 Head and Neck Neoplasms 246 Melanoma 240 Precursor Cell Lymphoblastic Leukemia-Lymphoma 209 Brain Neoplasms 195 Lymphoma, Large B-Cell, Diffuse 184 Nasopharyngeal Carcinoma 180 Lymphoma, Non-Hodgkin 173 Leukemia 173 Liver Neoplasms 163 Glioblastoma 158 Urinary Bladder Neoplasms 153

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Interventional × GATA2 Deficiency × Clear all

NCT03018405 2019-09-19

THINK

Celyad Oncology SA

Phase 1/2 Unknown

GATA2 Deficiency, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡